About this scholarly article

Is High-Dose Nafamostat Mesilate Effective for the Prevention of Post-ERCP Pancreatitis, Especially in High-Risk Patients? by Park, Kee Tae; Kang, Dae Hwan; Choi, Cheol Woong; Cho, Mong; Park, Su Bum; Kim, Hyung Wook; Kim, Dong Uk; Chung, Chung Wook; Yoon, Ki Tae is a scholarly article available to read on EtoBox.

Author

Park, Kee Tae; Kang, Dae Hwan; Choi, Cheol Woong; Cho, Mong; Park, Su Bum; Kim, Hyung Wook; Kim, Dong Uk; Chung, Chung Wook; Yoon, Ki Tae

Publisher

Lippincott Williams and Wilkins; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 0885-3177)

Published

2011